Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (301-310 of 451) with videos related to

Pageof 46
Sort By:
Gastroenterology|July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 ScoresGeorge N Ioannou, Lauren A Beste, Pamela K Green, et al.
The Journal of Infectious Diseases|August 13, 2010
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug usersLauren M Kucirka, Homayoon Farzadegan, Jordan J Feld, et al.
American Journal of Hematology|July 6, 2013
Liver stiffness increases acutely during sickle cell vaso-occlusive crisisChristopher Koh, Tiffany Turner, Xiongce Zhao, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2015
Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis BH Chi, B E Hansen, C Yim, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|August 27, 2025
National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concernSimone Périnet, Anson Williams, Laurence Campeau, et al.
Cytokine|June 18, 2018
IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signalingFatemeh Vahedi, Amanda J Lee, Susan E Collins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2025
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in PregnancyAndrew B Mendlowitz, Jennifer A Flemming, Tatyana Kushner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic ReviewChristine C Hsu, Harish Gopalakrishna, Maria Mironova, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 27, 2020
Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive studyMia J Biondi, Alex Marchand-Austin, Kirby Cronin, et al.
Haematologica|August 4, 2006
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature reviewJane A Little, Vicki R McGowan, Gregory J Kato, et al.
Pageof 46

Showing results (301-310 of 451) with videos related to

Sort By:
Pageof 46
Gastroenterology|July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 ScoresGeorge N Ioannou, Lauren A Beste, Pamela K Green, et al.
The Journal of Infectious Diseases|August 13, 2010
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug usersLauren M Kucirka, Homayoon Farzadegan, Jordan J Feld, et al.
American Journal of Hematology|July 6, 2013
Liver stiffness increases acutely during sickle cell vaso-occlusive crisisChristopher Koh, Tiffany Turner, Xiongce Zhao, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2015
Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis BH Chi, B E Hansen, C Yim, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|August 27, 2025
National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concernSimone Périnet, Anson Williams, Laurence Campeau, et al.
Cytokine|June 18, 2018
IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signalingFatemeh Vahedi, Amanda J Lee, Susan E Collins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2025
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in PregnancyAndrew B Mendlowitz, Jennifer A Flemming, Tatyana Kushner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic ReviewChristine C Hsu, Harish Gopalakrishna, Maria Mironova, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 27, 2020
Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive studyMia J Biondi, Alex Marchand-Austin, Kirby Cronin, et al.
Haematologica|August 4, 2006
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature reviewJane A Little, Vicki R McGowan, Gregory J Kato, et al.
Pageof 46